Novavax, Inc. (NVAX)
10.46
-0.14
(-1.32%)
USD |
NASDAQ |
Oct 02, 16:00
10.44
-0.02
(-0.19%)
After-Hours: 20:00
Novavax Price : 10.46 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 10.80 | 10.86 | 10.33 | 10.46 | 4.025M |
| Oct 01, 2026 | 10.75 | 10.98 | 10.54 | 10.60 | 3.150M |
| Sep 30, 2026 | 10.85 | 11.10 | 10.54 | 10.81 | 4.566M |
| Sep 29, 2026 | 10.80 | 11.11 | 10.41 | 10.82 | 4.071M |
| Sep 28, 2026 | 10.50 | 10.98 | 10.26 | 10.80 | 4.462M |
| Sep 25, 2026 | 10.62 | 10.79 | 10.34 | 10.63 | 3.910M |
| Sep 24, 2026 | 10.42 | 10.85 | 10.38 | 10.60 | 4.353M |
| Sep 23, 2026 | 10.79 | 10.94 | 10.46 | 10.55 | 5.773M |
| Sep 22, 2026 | 10.39 | 11.09 | 10.15 | 10.83 | 7.581M |
| Sep 21, 2026 | 10.38 | 10.70 | 10.21 | 10.41 | 6.135M |
| Sep 18, 2026 | 9.89 | 10.14 | 9.76 | 10.11 | 11.15M |
| Sep 17, 2026 | 9.615 | 10.38 | 9.61 | 10.00 | 8.876M |
| Sep 16, 2026 | 9.35 | 9.41 | 9.155 | 9.35 | 2.849M |
| Sep 15, 2026 | 9.50 | 9.56 | 9.16 | 9.23 | 3.332M |
| Sep 14, 2026 | 9.38 | 9.60 | 9.135 | 9.59 | 3.367M |
| Sep 11, 2026 | 9.29 | 9.865 | 9.23 | 9.42 | 6.121M |
| Sep 10, 2026 | 9.64 | 9.68 | 9.11 | 9.30 | 5.893M |
| Sep 09, 2026 | 10.02 | 10.24 | 9.73 | 9.85 | 4.444M |
| Sep 08, 2026 | 10.10 | 10.36 | 9.75 | 10.19 | 4.231M |
| Sep 04, 2026 | 10.50 | 10.75 | 10.04 | 10.22 | 5.125M |
| Sep 03, 2026 | 10.42 | 10.48 | 9.900 | 10.34 | 6.227M |
| Sep 02, 2026 | 10.28 | 10.73 | 9.96 | 10.32 | 5.636M |
| Sep 01, 2026 | 9.20 | 10.26 | 9.19 | 10.12 | 10.04M |
| Aug 31, 2026 | 9.10 | 9.985 | 9.09 | 9.37 | 7.272M |
| Aug 28, 2026 | 9.18 | 9.34 | 8.89 | 9.26 | 4.212M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Merck & Co., Inc. | 144.30 |
| Pfizer Inc. | 27.80 |
| Agenus, Inc. | 8.36 |
| Editas Medicine, Inc. | 2.62 |
| Recursion Pharmaceuticals, Inc. | 4.12 |
Price Related Metrics
| PS Ratio | 4.142 |
| Earnings Yield | -14.56% |
| Market Cap | 1.724B |